Borderline Resectable Pancreatic Cancer

Bhargava Mullapudi, Patrick J. Hawkes, Asish Patel, Chandrakanth Are, Subhasis Misra

Research output: Contribution to journalReview articlepeer-review


Borderline resectable pancreatic cancer (BRPC) is an evolving diagnostic entity that blurs the distinction between resectable and locally advanced pancreatic cancer (Varadhachary et al. Ann Surg Oncol 13:1035–1046, 2006). Until recently the management of this disease has been poorly defined; however, consensus guidelines have been developed regarding the proper management of this diagnostic entity. Recent studies have shown that if appropriately identified and treated, this subset of disease can have outcomes similar to pancreatic cancer that is defined as resectable (Laurence et al. J Gastrointest Surg 15:2059–2069, 2011). The aim of this review is to outline the current consensus on definitions, workup and management of BRPC, and also provide a summary of issues that require progress as defined by the International Study Group of Pancreatic Surgery (ISGPS).

Original languageEnglish (US)
Pages (from-to)63-68
Number of pages6
JournalIndian Journal of Surgical Oncology
Issue number1
StatePublished - Mar 1 2015


  • Borderline
  • Pancreas
  • Pancreatic cancer
  • Pancreaticoduodenectomy
  • Whipple

ASJC Scopus subject areas

  • Surgery
  • Oncology


Dive into the research topics of 'Borderline Resectable Pancreatic Cancer'. Together they form a unique fingerprint.

Cite this